SONENDO INC - SONX STOCK NEWS

Sonendo, a dental technology company, announces its sponsorship of Save Your Tooth Month 2023, promoting the benefits of endodontic treatment. This initiative, organized by the American Association of Endodontists (AAE), involves various activities throughout May. Sonendo has been a sponsor since 2020 and will continue to support the campaign until at least 2024. Additionally, Sonendo will participate in the 2023 AAE Annual Meeting in Chicago from May 3-6, showcasing its GentleWave G4 System and proprietary CleanFlow Technology. The company has committed to donating $50,000 to the AAE's Foundation for Endodontics for research and education. Sonendo focuses on saving teeth from decay through its GentleWave® System, offering improved clinical outcomes with less invasive procedures.

Sonendo, a dental technology company, announced it will report its financial results for Q1 2023 after market close on May 9, 2023. A conference call will follow at 1:30 PM PT. Investors can access the call by dialing (833) 470-1428 or via the company's website. Sonendo is known for its GentleWave^® System, an innovative treatment for tooth decay, aiming to improve clinical outcomes while minimizing pain and preserving tooth structure. The company also owns TDO^® Software, enhancing dental practice efficiency. This announcement reaffirms Sonendo’s commitment to transparency and investor engagement.

Sonendo, Inc. (NYSE: SONX) announced leadership changes, effective June 1, 2023, as COO Andrew Kirkpatrick steps down to pursue new opportunities. To enhance operational efficiency, John McGaugh joins as Vice President of Operations, bringing over 20 years of experience, including roles at Abbott Vascular and Boston Scientific. The company aims to improve its gross margin profile, a critical initiative highlighted by President and CEO Bjarne Bergheim. Additionally, Kevin Yein has been promoted to Vice President of R&D, recognized for his contributions to product innovations like the GentleWave G4 System. Both leaders will report to Bergheim and are expected to drive growth and operational enhancements within the company.

Sonendo reported strong financial results for Q4 2022, with total revenue of $12.2 million, a 24% increase year-over-year, and total revenue for 2022 reaching $41.7 million, up 25% from 2021. Notable growth in consumable revenue was 31% in Q4. The installed base reached 976 units by year-end. Despite this growth, the company faced a net loss of $10.9 million in Q4 and $57.1 million for the full year. Operating expenses rose to $68.7 million, leading to a 58.2 million loss from operations. For 2023, Sonendo anticipates total revenue to be between $48.0 million and $51.0 million.

Sonendo (NYSE: SONX), a leader in dental technology, announces further investments in the specialty of endodontics, focusing on clinical training and education. Since late-2020, Sonendo has supported over 20 endodontic residency programs, training approximately 75 residents to utilize its GentleWave® System, which offers a less painful alternative to traditional root canal treatments. The company is also actively involved in research, with 18 projects ongoing, and sponsors the American Association of Endodontists. In 2022, Sonendo organized over 130 professional education events across North America to enhance clinician knowledge.

Sonendo, Inc. (NYSE: SONX) will release its financial results for Q4 and full year 2022 on March 8, 2023, following market close. A conference call will be held at 1:30 p.m. Pacific Time to discuss these results. Investors can participate by calling (844) 200-6205 or (929) 526-1599, using access code 340170. A live audio webcast will also be available on the company's investor website, with an archived recording accessible for at least 90 days. Sonendo is known for its GentleWave® System, which treats tooth decay using innovative technology to enhance clinical outcomes and improve dental practice workflows.

Sonendo, a dental technology company, has launched a new brand campaign and website, reaffirming its commitment to endodontics and enhancing patient care. The campaign showcases clinicians utilizing the GentleWave System, emphasizing their role in advancing root canal procedures. With over one million patients treated, the campaign aims to change misconceptions about root canal therapy. The company also offers educational programs and marketing support for clinicians. CEO Bjarne Bergheim highlighted the importance of simplifying complex procedures to improve patient experiences.

Sonendo, Inc. (NYSE: SONX) announced that its subsidiary, PIPStek LLC, has filed a patent infringement lawsuit against BIOLASE, Inc. in the U.S. District Court for Delaware. The suit asserts that BIOLASE's Waterlase laser infringes on two patents owned by PIPStek. Sonendo acquired PIPStek in 2017, securing its intellectual property, which includes dental laser technologies. CEO Bjarne Bergheim emphasized their commitment to protect intellectual property and expressed confidence in a favorable court ruling.